Cargando…

Transdermal Delivery of α-Aminophosphonates as Semisolid Formulations—An In Vitro-Ex Vivo Study

α-Aminophosphonates are organophosphorus compounds with an obvious similarity with α-amino acids. Owing to their biological and pharmacological characteristics, they have attracted the attention of many medicinal chemists. α-Aminophosphonates are known to exhibit antiviral, antitumor, antimicrobial,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kocsis, Dorottya, Varga, Petra Regina, Keshwan, Rusul, Nader, Mina, Lengyel, Miléna, Szabó, Pál, Antal, István, Kánai, Károly, Keglevich, György, Erdő, Franciska
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220917/
https://www.ncbi.nlm.nih.gov/pubmed/37242706
http://dx.doi.org/10.3390/pharmaceutics15051464
_version_ 1785049331998392320
author Kocsis, Dorottya
Varga, Petra Regina
Keshwan, Rusul
Nader, Mina
Lengyel, Miléna
Szabó, Pál
Antal, István
Kánai, Károly
Keglevich, György
Erdő, Franciska
author_facet Kocsis, Dorottya
Varga, Petra Regina
Keshwan, Rusul
Nader, Mina
Lengyel, Miléna
Szabó, Pál
Antal, István
Kánai, Károly
Keglevich, György
Erdő, Franciska
author_sort Kocsis, Dorottya
collection PubMed
description α-Aminophosphonates are organophosphorus compounds with an obvious similarity with α-amino acids. Owing to their biological and pharmacological characteristics, they have attracted the attention of many medicinal chemists. α-Aminophosphonates are known to exhibit antiviral, antitumor, antimicrobial, antioxidant and antibacterial activities, which can all be important in pathological dermatological conditions. However, their ADMET properties are not well studied. The aim of the current study was to provide preliminary information about the skin penetration of three preselected α-aminophosphonates when applying them as topical cream formulations in static and dynamic diffusion chambers. The results indicate that aminophosphonate 1a, without any substituent in the para position, shows the best release from the formulation and the highest absorption through the excised skin. However, based on our previous study, the in vitro pharmacological potency was higher in the case of para-substituted molecules 1b and 1c. The particle size and rheological studies revealed that the 2% cream of aminophosphonate 1a was the most homogenous formulation. In conclusion, the most promising molecule was 1a, but further experiments are proposed to uncover the possible transporter interactions in the skin, optimize the topical formulations and improve PK/PD profiles in case of transdermal delivery.
format Online
Article
Text
id pubmed-10220917
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102209172023-05-28 Transdermal Delivery of α-Aminophosphonates as Semisolid Formulations—An In Vitro-Ex Vivo Study Kocsis, Dorottya Varga, Petra Regina Keshwan, Rusul Nader, Mina Lengyel, Miléna Szabó, Pál Antal, István Kánai, Károly Keglevich, György Erdő, Franciska Pharmaceutics Article α-Aminophosphonates are organophosphorus compounds with an obvious similarity with α-amino acids. Owing to their biological and pharmacological characteristics, they have attracted the attention of many medicinal chemists. α-Aminophosphonates are known to exhibit antiviral, antitumor, antimicrobial, antioxidant and antibacterial activities, which can all be important in pathological dermatological conditions. However, their ADMET properties are not well studied. The aim of the current study was to provide preliminary information about the skin penetration of three preselected α-aminophosphonates when applying them as topical cream formulations in static and dynamic diffusion chambers. The results indicate that aminophosphonate 1a, without any substituent in the para position, shows the best release from the formulation and the highest absorption through the excised skin. However, based on our previous study, the in vitro pharmacological potency was higher in the case of para-substituted molecules 1b and 1c. The particle size and rheological studies revealed that the 2% cream of aminophosphonate 1a was the most homogenous formulation. In conclusion, the most promising molecule was 1a, but further experiments are proposed to uncover the possible transporter interactions in the skin, optimize the topical formulations and improve PK/PD profiles in case of transdermal delivery. MDPI 2023-05-11 /pmc/articles/PMC10220917/ /pubmed/37242706 http://dx.doi.org/10.3390/pharmaceutics15051464 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kocsis, Dorottya
Varga, Petra Regina
Keshwan, Rusul
Nader, Mina
Lengyel, Miléna
Szabó, Pál
Antal, István
Kánai, Károly
Keglevich, György
Erdő, Franciska
Transdermal Delivery of α-Aminophosphonates as Semisolid Formulations—An In Vitro-Ex Vivo Study
title Transdermal Delivery of α-Aminophosphonates as Semisolid Formulations—An In Vitro-Ex Vivo Study
title_full Transdermal Delivery of α-Aminophosphonates as Semisolid Formulations—An In Vitro-Ex Vivo Study
title_fullStr Transdermal Delivery of α-Aminophosphonates as Semisolid Formulations—An In Vitro-Ex Vivo Study
title_full_unstemmed Transdermal Delivery of α-Aminophosphonates as Semisolid Formulations—An In Vitro-Ex Vivo Study
title_short Transdermal Delivery of α-Aminophosphonates as Semisolid Formulations—An In Vitro-Ex Vivo Study
title_sort transdermal delivery of α-aminophosphonates as semisolid formulations—an in vitro-ex vivo study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220917/
https://www.ncbi.nlm.nih.gov/pubmed/37242706
http://dx.doi.org/10.3390/pharmaceutics15051464
work_keys_str_mv AT kocsisdorottya transdermaldeliveryofaaminophosphonatesassemisolidformulationsaninvitroexvivostudy
AT vargapetraregina transdermaldeliveryofaaminophosphonatesassemisolidformulationsaninvitroexvivostudy
AT keshwanrusul transdermaldeliveryofaaminophosphonatesassemisolidformulationsaninvitroexvivostudy
AT nadermina transdermaldeliveryofaaminophosphonatesassemisolidformulationsaninvitroexvivostudy
AT lengyelmilena transdermaldeliveryofaaminophosphonatesassemisolidformulationsaninvitroexvivostudy
AT szabopal transdermaldeliveryofaaminophosphonatesassemisolidformulationsaninvitroexvivostudy
AT antalistvan transdermaldeliveryofaaminophosphonatesassemisolidformulationsaninvitroexvivostudy
AT kanaikaroly transdermaldeliveryofaaminophosphonatesassemisolidformulationsaninvitroexvivostudy
AT keglevichgyorgy transdermaldeliveryofaaminophosphonatesassemisolidformulationsaninvitroexvivostudy
AT erdofranciska transdermaldeliveryofaaminophosphonatesassemisolidformulationsaninvitroexvivostudy